Direktorat Registrasi ObatValid

GABAPENTIN

BPOM Number: GKL1905518901A1
Approved: 21 November 2024
Expiry: 23 May 2024
Form: KAPSUL; 100 MG

About This Registration

GABAPENTIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1905518901A1. Its current registration status is Valid, with the licence valid until 23 May 2024. The product is registered to ACTAVIS INDONESIA - INDONESIA. BPOM first approved this registration in May 2019. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 5 BLISTER @ 10 KAPSUL
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

ACTAVIS INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 010005254052000
owner
View profile →

Manufacturing Sites

ACTAVIS INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Ingredients (1)

GABAPENTIN

Market Intelligence

Owner Portfolio: ACTAVIS INDONESIA - INDONESIA holds 164 BPOM registrations
Manufacturer Scale: ACTAVIS INDONESIA - INDONESIA produces 164 registered products
Registration Age: Registered for 7 years, 4 months
Expiry Status: Expired 854 days ago

FDA Cross-Reference

via openFDA

Generic Name: GABAPENTIN
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?